Search research articles
Contact Us
Filters
Showing results (641-650 of 675) with videos related to
Page
of 68
Sort By:
Journal of the National Cancer Institute
|
February 5, 2019
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy
Maria B Koenigs, Armida Lefranc-Torres, Juliana Bonilla-Velez, et al.
European Urology Oncology
|
January 11, 2022
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14
Cyrill A Rentsch, George N Thalmann, Ilaria Lucca, et al.
Cancer Research
|
September 27, 2017
PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4<sup>+</sup> TILs in the Presence of PD-L1<sup>+</sup> TAMs
Austin K Mattox, Jina Lee, William H Westra, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 22, 2025
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
Matthew D Ringel, Julie Ann Sosa, Zubair Baloch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2021
Screening and Validation of Molecular Targeted Radiosensitizers
Henning Willers, Xiao Pan, Nathalie Borgeaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
J J Lin, S V Liu, C E McCoach, et al.
Plos One
|
August 4, 2023
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival
Malek Z O Hassan, Ahmed Tawakol, Ying Wang, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Cancer Medicine
|
December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancer
David G Pfister, Robert I Haddad, Francis P Worden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Glenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Page
of 68
Search research articles
Search
Showing results (641-650 of 675) with videos related to
Sort By:
Page
of 68
Journal of the National Cancer Institute
|
February 5, 2019
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy
Maria B Koenigs, Armida Lefranc-Torres, Juliana Bonilla-Velez, et al.
European Urology Oncology
|
January 11, 2022
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14
Cyrill A Rentsch, George N Thalmann, Ilaria Lucca, et al.
Cancer Research
|
September 27, 2017
PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4<sup>+</sup> TILs in the Presence of PD-L1<sup>+</sup> TAMs
Austin K Mattox, Jina Lee, William H Westra, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 22, 2025
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
Matthew D Ringel, Julie Ann Sosa, Zubair Baloch, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 3, 2021
Screening and Validation of Molecular Targeted Radiosensitizers
Henning Willers, Xiao Pan, Nathalie Borgeaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 2, 2020
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer
J J Lin, S V Liu, C E McCoach, et al.
Plos One
|
August 4, 2023
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival
Malek Z O Hassan, Ahmed Tawakol, Ying Wang, et al.
The New England Journal of Medicine
|
October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid Cancer
Julien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Cancer Medicine
|
December 8, 2022
Biomarkers predictive of response to pembrolizumab in head and neck cancer
David G Pfister, Robert I Haddad, Francis P Worden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study
Glenn J Hanna, Naifa L Busaidy, Nicole G Chau, et al.
Page
of 68